Journal of the National Comprehensive Cancer Network

Title Publication Date Language Citations
CGE24-095: Microfluidic Characterization and Analysis of Circulating Tumor Cells from Patients with Metastatic Melanoma2024/04/05
HSR24-170: Utilization of Biomarker Testing and Biomarker-Driven Targeted Therapy Among Patients With Metastatic Non–Small Cell Lung Cancer2024/04/05
CLO24-080: Association Between Primary Tumor Size and Prognosis in De Novo Metastatic Renal Cell Carcinoma in Patients Who Underwent First Line Immunotherapy-Based Therapy: Real World Data Analysis2024/04/05
HSR24-146: Chemotherapy-Induced Febrile Neutropenia (FN) in the US: Healthcare Resource Utilization (HCRU) and Costs2024/04/05
HSR24-132: Value of Early Transfusion Burden Reduction in Lower-Risk Myelodysplastic Syndromes (LR-MDS)2024/04/05
QIM24-185: Reimagining the Pathology Report: Virtual 3D Specimen Mapping in Oncologic Surgery2024/04/05
CLO24-086: The Effect of TBI-Based Conditioning Regimen on Recurrence and Transplant-Related Mortality Among Patients With Mantle Cell Lymphoma Who Received Autologous Bone Marrow Transplant2024/04/05
BPI24-022: Our Approach to Patient Selection for Polatuzumab-Based Therapy in Advanced Diffuse Large B-Cell Lymphoma2024/04/05
HSR24-124: Determinants of Quality of Life and Optimism in Patients With EGFR Mutated Advanced Non–Small Cell Lung Cancer2024/04/05
HSR24-129: Impact of Socioeconomic Status on Cancer Care in Southeast Texas: A Population-Based Cohort Study2024/04/05
BIO24-032: Early Diagnosis of Cancer Cachexia Using Body Composition Index as the Radiographic Biomarker2024/04/05
CRE24-033: Complete Remission of Microsatellite Instability–High (MSI-H) Oligometastatic Poorly Differentiated Colon Adenocarcinoma After a Single Dose of Immunotherapy2024/04/05
HSR24-137: Does Routine Clinical Assessment of Older Adults With Gastroesophageal Cancer Tell the Whole Story?2024/04/05
HSR24-142: Real-World Clinical Benefit Among Patients (pts) With Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated With Luspatercept2024/04/05
QIM24-190: A Safety Net System for Significant Diagnostic Imaging Actionable Findings at a Comprehensive Cancer Care Center2024/04/05
TIP24-198: A Multi-Center Phase I Trial of Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Refractory Gastric Cancer Patients2024/04/05
HSR24-127: Rectal Cancer Disparities in Age and Overall Survival Among American Indian and Alaska Native Vs Non-Hispanic White Populations2024/04/05
QIM24-192: Place of Death From Cancer in Episodic Value Based Care Models in a Community Oncology Network2024/04/05
YIA24-004: Liquid Biomarkers of Response to Radium-223 in Metastatic Prostate Cancer2024/04/05
CLO24-063: Red Cell Distribution Width and Putative Severity Markers as Predictors of Short-Term Critical Illness in Hospitalized Cancer Patients2024/04/05
HSR24-152: Patient-Reported Outcome (PRO) Data in Oncology NDAs Approved by the FDA (2018–2021): A Review of Criticism and Concerns in Comments From Regulators2024/04/05
CLO24-082: A National Cancer Data Base (NCDB) Analysis of Prognostic Factors in Metastatic Triple-Negative Breast Cancer (TNBC)2024/04/05
HSR24-144: Does Immunotherapy Work in Patients With Poor Performance Status?2024/04/05
CLO24-059: The Impact of Proton Pump Inhibitors on Palbociclib in Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis2024/04/05
CRE24-049: Extrapulmonary Small Cell Carcinoma of Gallbladder Presenting as Acute Cholecystitis2024/04/05
EPR24-111: The Clinical Effect of a Community-Based Genetic Testing Program2024/04/05
EPR24-104: Re-Evaluating Breast Cancer Screening Recommendations: An Analysis of Breast Cancer Incidence by Age Groups2024/04/05
HSR24-157: Standalone Performance Evaluation of an Artificial Intelligence Breast Cancer Detection Tool on Consecutively Collected Biopsy Proven Breast Cancer and Screening Negative Tomosynthesis Cases2024/04/05
HSR24-138: Real-World Treatment (tx) Patterns and Outcomes for First-Line (1L) Novel Hormonal Agent (NHA) Naïve Metastatic Castration Resistant Prostate Cancer (mCRPC) Including in Black and/or African American (BAA) Patients (Pts)2024/04/05
HSR24-150: Real-World Treatment Patterns of Selumetinib Among Patients With Neurofibromatosis Type I and Plexiform Neurofibroma in the United States2024/04/05